Enanta Pharmaceuticals (ENTA) PT Lowered to $14 at Oppenheimer
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Price: $13.00 +1.33%
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
15 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $14.00 (from $16.00) while maintaining a Perform rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Duos Technologies Group (DUOT) PT Raised to $27 at Cantor Fitzgerald on 'Extremely Attractive' Risk/Reward
- Scorpio Tankers (STNG) PT Lowered to $76 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
